Invention Grant
- Patent Title: Non-recombinant human insulin-like growth factor binding protein concentrate
-
Application No.: US16949817Application Date: 2020-11-16
-
Publication No.: US12167255B2Publication Date: 2024-12-10
- Inventor: Spencer Lin , Kwasi Osae-Kwapong , Omar Quraishi , Seema Sinha , Michele Smith , SunRay DiFrancesco , Ryan Spears , Dharini Rawal , Debra Hovanec-Burns , Robert Owens
- Applicant: Siemens Healthcare Diagnostics Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Siemens Healthcare Diagnostics Inc.
- Current Assignee: Siemens Healthcare Diagnostics Inc.
- Current Assignee Address: US NY Tarrytown
- Main IPC: H04W24/02
- IPC: H04W24/02 ; A61K38/00 ; A61K38/17 ; C07K14/435 ; C07K14/47 ; G01N33/96 ; H04B7/06 ; H04L41/0806 ; H04W8/00 ; H04W72/044 ; H04W84/18
Abstract:
A human insulin-like growth factor (IGF) binding protein stock solution and method of making the same include a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium. The concentration of the nr-IGFBP-3 in the stock solution ranges from about 16 micrograms per milliliter (μg/ml) to about 40 μg/ml. A kit includes a set of calibrators for nr-IGFBP-3. The set of calibrators includes the nr-IGFBP-3 in different concentrations.
Public/Granted literature
- US20210072266A1 NON-RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN CONCENTRATE Public/Granted day:2021-03-11
Information query
